Institute of Metabolic Science - Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.
School of Clinical Medicine, University of Cambridge, Cambridge, U.K.
Diabetes Care. 2024 Oct 1;47(10):1855-1868. doi: 10.2337/dc24-0725.
The increased risk of pregnancy complications in type 1 diabetes is mainly attributed to maternal hyperglycemia. However, it is unclear whether other potentially modifiable factors also contribute to risk in this population.
We sought to assess whether high BMI and excessive gestational weight gain (GWG) are associated with perinatal complications in type 1 diabetes.
We searched Medline, Embase, PubMed, Scopus, Web of Science, and Cochrane databases to January 2024.
Studies examining associations between periconception BMI or GWG and perinatal complications in type 1 diabetes were included.
We used a predesigned data extraction template to extract study data including year, country, sample size, participants' characteristics, exposure, and outcomes.
We included 29 studies (18,965 pregnancies; 1978-2019) in the meta-analysis. A 1 kg/m2/1 kg increase in preconception BMI or GWG was associated with a 3% and 11% increase, respectively, in perinatal complications (BMI odds ratio [OR] 1.03 [95% CI 1.01-1.06]; GWG OR 1.11 [95% CI 1.04-1.18]). Preconception BMI ≥ 25 kg/m2 or excessive GWG was associated with a 22% and 50% increase, respectively, in perinatal complications (BMI OR 1.22 [95% CI 1.11-1.34]; GWG OR 1.50 [95% CI 1.31-1.73]). BMI was associated with congenital malformation, preeclampsia, and neonatal intensive care unit admission. Excessive GWG was associated with preeclampsia, cesarean delivery, large for gestational age, and macrosomia.
Limitations included retrospective study design, variable measurement for exposures and outcomes, small number of studies for some outcomes, and no data from Asia and Africa.
Addressing maternal BMI prepregnancy and preventing excessive GWG should be key clinical priorities to improve outcomes in pregnant women with type 1 diabetes.
1 型糖尿病孕妇妊娠并发症风险增加主要归因于母体高血糖。然而,目前尚不清楚其他潜在可改变的因素是否也会增加该人群的风险。
我们旨在评估高体重指数(BMI)和过度妊娠体重增加(GWG)是否与 1 型糖尿病的围产期并发症相关。
我们检索了 Medline、Embase、PubMed、Scopus、Web of Science 和 Cochrane 数据库,检索时间截至 2024 年 1 月。
纳入研究 1 型糖尿病中围孕期 BMI 或 GWG 与围产期并发症之间关系的研究。
我们使用预设计的数据提取模板提取研究数据,包括年份、国家、样本量、参与者特征、暴露因素和结局。
Meta 分析纳入 29 项研究(18965 例妊娠;1978-2019 年)。孕前 BMI 或 GWG 每增加 1kg/m2 或 1kg,围产期并发症的风险分别增加 3%和 11%(BMI 比值比 [OR] 1.03 [95%CI 1.01-1.06];GWG OR 1.11 [95%CI 1.04-1.18])。孕前 BMI≥25kg/m2 或 GWG 过度与围产期并发症的风险分别增加 22%和 50%(BMI OR 1.22 [95%CI 1.11-1.34];GWG OR 1.50 [95%CI 1.31-1.73])。BMI 与先天性畸形、子痫前期和新生儿重症监护病房(NICU)入院相关。GWG 过度与子痫前期、剖宫产、大于胎龄儿和巨大儿相关。
局限性包括回顾性研究设计、暴露和结局的测量变量不同、一些结局的研究数量较少,以及没有来自亚洲和非洲的数据。
解决孕妇孕前 BMI 问题和预防 GWG 过度应成为改善 1 型糖尿病孕妇妊娠结局的重点临床要务。